Vistim Labs
David Scholes is a seasoned entrepreneur and business leader, currently serving as the CEO and Managing Partner at Chrome Fund since November 2020. Scholes holds several key positions, including Chairman of Cobalt Trust and Strategic Partner at Bridgepointe Technologies, both established in 2023. Notably, Scholes co-founded DeFacto in May 2016 and has been actively involved in philanthropy as the founder of AB Philanthropy since October 1999. Scholes has also expanded influence as a shareholder in Rhode Island FC and Drink Barcode™, and a member of the Board of Advisors for BlueBlue, LLC. Additionally, Scholes contributes strategic insights to Vistim Labs and DFND, highlighting a commitment to innovative solutions in healthcare. Scholes is an alumnus of Yale University.
This person is not in any teams
This person is not in any offices
Vistim Labs
1 followers
Vistim Labs is a MedTech diagnostic company that helps to detect, treat, and track neurological disorders. The company offers a brain scan for high-precision measurement of cognition function and treatment efficacy.